Investor Overview - CareSpan Health, Inc.

Skip to content

Our Covid Response

Home
Purpose
Platform
Networks
About Us ▼
- Our Team
- Publications
Investors ▼
- Press
- SEDAR Filings
Contact Us

Investor Overview

CareSpan Investor Overview

To download the CareSpan Investor Overview presentation, please provide the following:

Name*

Company*

Email*

Phone

If you are human, leave this field blank.

Purpose
Platform
Networks
Press
Team
Contact Us

Mailing Address

105 E 34th St Suite #107 New York, New York 10016

Phone:

(303) 800-8296

Fax:

(303) 800-8226

COVID Response:

CareSpan USA, developer of the CareSpan® Clinic integrated digital care platform, has developed and launched a screening-and-response program for individuals concerned that they may have contracted the new coronavirus and are at risk for or may have COVID-19. The CareSpan COVID-19 Screening-and-Response (S&R) Program was designed with input from physicians, nurse practitioners, and doctors-of-public-health to enable risk assessment, testing referral and counseling and/or care of anyone concerned about the new coronavirus disease, regardless of location. The first clinicians using the CareSpan COVID-19 S&R Program are members of American-APN, a multi-state network of nurse practitioners using the CareSpan Clinic platform for care delivery. Likewise, Global Health, the occupational medicine arm of Houston Area Safety Council, a CareSpan client, is offering the COVID-19 S&R Program to its industrial employer clientele for screening of workers in the energy, refining, chemical, and construction sectors.